{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T08:21:35Z","timestamp":1787473295857,"version":"build-2736575974"},"reference-count":22,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Irregular antibodies with the potential for causing transfusion reactions can be detected in healthy donors. The prevalence and characteristics of irregular antibodies in many populations are well known; however, the data of Vietnamese blood donors have not yet been reported. Our study was performed to assess the frequency and specificities of irregular antibodies among healthy blood donors in the north of Vietnam. A total of 199,281 blood donor samples were screened for irregular antibodies from 2021 to 2023. Antibody screening was performed by both microplate and tube methods. Positive tests were further confirmed using a gel card method. Subsequently, antibody identification was performed. The occurrence of a positive antibody detection test was 0.37 percent. Most cases had only one antibody (99.1%); the proportion of donors who had two and three antibodies accounted for 0.8 and 0.1 percent, respectively. The most frequently identified antibodies were of the MNS blood group system, with anti-Mi\n                    <jats:sup>a<\/jats:sup>\n                    being the highest (72.7%) and then anti-M (12.9%), followed by the Lewis blood group system with anti-Le\n                    <jats:sup>a<\/jats:sup>\n                    (6.5%) and anti-Leb (2.4%). The results show the rate and characteristics of irregular antibodies in northern Vietnamese blood donors. These findings provide essential data to support recommendations for implementing antibody detection in donor testing nationwide. Moreover, the results underscore the importance of selecting appropriate reagent panels.\n                  <\/jats:p>","DOI":"10.2478\/immunohematology-2025-013","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:57:18Z","timestamp":1761890238000},"page":"84-89","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and characteristics of irregular antibodies in northern Vietnamese blood donors"],"prefix":"10.2478","volume":"41","author":[{"given":"Tung","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Hematology and Blood Transfusion , Hanoi Medical University , Hanoi , Vietnam"},{"name":"Department of Quality Management , National Institute of Hematology and Blood Transfusion , Hanoi , Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nga","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Blood Group Serology , National Institute of Hematology and Blood Transfusion , Hanoi , Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Blood Screening , National Institute of Hematology and Blood Transfusion , Hanoi , Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Hematology and Blood Transfusion , Hanoi Medical University , Hanoi , Vietnam"},{"name":"Director of the National Institute of Hematology and Blood Transfusion , Hanoi , Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"2026082308010063087_j_immunohematology-2025-013_ref_001","doi-asserted-by":"crossref","unstructured":"Hashem AEA, Mostafa GMH, El-Faramawy MSM. Red blood cell alloantibodies in healthy Egyptian blood donors. Egyptian J Hospital Med 2018;72:4913\u20138.","DOI":"10.21608\/ejhm.2018.10173"},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_002","doi-asserted-by":"crossref","unstructured":"Strobel E. Hemolytic transfusion reactions. Transfus Med Hemother 2008;35:346\u201353.","DOI":"10.1159\/000154811"},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_003","unstructured":"Canadian Blood Services. Clinical guide to transfusion. Version 4.0. Ottawa: Canadian Blood Services, 2019."},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_004","unstructured":"Joint United Kingdom Blood Transfusion and Tissue Transplantation Services (JPAC). Mandatory testing of blood donations. Available from https:\/\/www.transfusionguidelines.org\/red-book\/chapter-12-donation-testing-red-cell-immunohaematology\/12-10-mandatory-testing-of-blood-donations. Accessed 5 August 2025."},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_005","unstructured":"Franchini M, Forni GL, Marano G, et al. Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review. Blood Transfus 2019;17:4\u201315."},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_006","doi-asserted-by":"crossref","unstructured":"Yadav A, Raturi G, Aparna B. Prevalence of irregular red cell antibody in transfusion recipients vis-a-vis healthy blood donors attending a tertiary care hospital in north India. Asian J Transfus Sci 2022;16:73\u20137.","DOI":"10.4103\/ajts.AJTS_118_19"},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_007","unstructured":"Nathani KJ, Patel J, Modi P, et al. Prevalence of red cell alloantibodies & autoantibodies in patient & donor attending a tertiary care hospital in south Gujarat. Int J Contemp Med Res 2021;8:C1\u20135."},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_008","doi-asserted-by":"crossref","unstructured":"Makroo RN, Rajput S, Agarwal S, et al. Prevalence of irregular red cell antibodies in healthy blood donors attending a tertiary care hospital in South India. Asian J Transfus Sci 2018;12: 17\u201320.","DOI":"10.4103\/ajts.AJTS_4_17"},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_009","unstructured":"Rolon TME, Hoyos GK, Correa OA, et al. Blood donors characterization with positive irregular antibodies in Monter\u00eda, Colombia, 2012\u20132015. Rev Cubana Hematol Inmunol Hemoter 2019;35:1\u201312."},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_010","doi-asserted-by":"crossref","unstructured":"Solanki A, Chandra T, Singh A. Prevalence of red blood cell antibodies in whole blood donors: a single-centre experience in north India. Indian J Med Res 2020;152:280\u20134.","DOI":"10.4103\/ijmr.IJMR_296_19"},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_011","doi-asserted-by":"crossref","unstructured":"Karafin MS, Tan A, Tormey CA, et al. Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Transfusion 2019;59:217\u201325.","DOI":"10.1111\/trf.15004"},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_012","doi-asserted-by":"crossref","unstructured":"Tiwari AK, Pandey P, Sharma J, et al. Incidence of clinically significant antibodies in patients and healthy blood donors: a prospective cross-sectional study from a tertiary healthcare center in India. Transfus Apher Sci 2014;50:230\u20134.","DOI":"10.1016\/j.transci.2013.08.008"},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_013","doi-asserted-by":"crossref","unstructured":"Hendrickson JE, Tormey CA. Understanding red blood cell alloimmunization triggers. Hematology 2016;1:446\u201351.","DOI":"10.1182\/asheducation-2016.1.446"},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_014","doi-asserted-by":"crossref","unstructured":"Garc\u00eda MA, Bautista L, Palomino F. Should blood donors be routinely screened for irregular antibodies? Immunohematology 2012;28:60\u20136.","DOI":"10.21307\/immunohematology-2019-151"},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_015","unstructured":"National Institute of Hematology and Blood Transfusion, Vietnam. Central Institute of Hematology and Blood Transfusion. Available from https:\/\/vienhuyethoc.vn\/nhommau-va-nhom-mau-hiem\/. Accessed 5 August 2025."},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_016","unstructured":"Nguyen TTT, Nguyen THH, \u0110ong SS, et al. Survey on the rate of the ABO and Rh(D) blood group systems of volunteer blood donors at Hue Blood Transfusion Center. Ho Chi Minh City J Med 2015;19:433."},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_017","doi-asserted-by":"crossref","unstructured":"Sivakaanthan A, Hollands S, Powley T, et al. Routine donor red cell antibody screening: considering the alternate strategy. Vox Sang 2022;117:708\u201314.","DOI":"10.1111\/vox.13235"},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_018","doi-asserted-by":"crossref","unstructured":"Promwong C, Siammai S, Hassarin S, et al. Frequencies and specificities of red cell alloantibodies in the southern Thai population. Asian J Transfus Sci 2013;7:16\u201320.","DOI":"10.4103\/0973-6247.106718"},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_019","doi-asserted-by":"crossref","unstructured":"Solanki A, Chaudhary RK, Sonker A, et al. Frequency and characterization of irregular red cell antibodies among blood donors in a tertiary care hospital in north India. Indian J Med Res 2020;152:632\u20138.","DOI":"10.4103\/ijmr.IJMR_296_19"},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_020","unstructured":"Choi HW, Kim S, Lee K, et al. Naturally occurring anti-Mi(a) detected in a young male patient. Ann Lab Med 2004;24: 202\u20134."},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_021","doi-asserted-by":"crossref","unstructured":"Nguyen TQ, Do TT, Hoang NTT, et al. Frequencies of different blood group antigens and phenotypes in northern Vietnamese donors. Transfus Med 2025;35:346\u201351.","DOI":"10.1111\/tme.13136"},{"key":"2026082308010063087_j_immunohematology-2025-013_ref_022","unstructured":"Cohn CS, Delaney M, Johnson ST, et al. AABB technical manual. 21st ed. Bethesda, MD: AABB, 2023:358."}],"container-title":["Immunohematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/immunohematology-2025-013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T08:01:36Z","timestamp":1787472096000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/immunohematology-2025-013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,10,31]]},"published-print":{"date-parts":[[2025,9,1]]}},"alternative-id":["10.2478\/immunohematology-2025-013"],"URL":"https:\/\/doi.org\/10.2478\/immunohematology-2025-013","relation":{},"ISSN":["1930-3955"],"issn-type":[{"value":"1930-3955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]}}}